Nicholas N. Vahanian
Keine laufenden Positionen mehr
Profil
Nicholas N.
Vahanian was the founder who founded NewLink Genetics Corp.
in 1999 and held the titles of President, Director & Chief Medical Officer from 2015 to 2017.
He also worked as President at Lumos Pharma, Inc. in a former job.
Dr. Vahanian earned an MBA degree from the University of Notre Dame and an undergraduate degree from Virginia Commonwealth University.
Ehemalige bekannte Positionen von Nicholas N. Vahanian
| Unternehmen | Position | Ende |
|---|---|---|
| LUMOS PHARMA, INC. | Gründer | 11.11.2019 |
| LUMOS PHARMA, INC. | Präsident | 27.09.2019 |
Ausbildung von Nicholas N. Vahanian
| Virginia Commonwealth University | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
